1
|
CLU
|
NM_001831
|
clusterin
|
literature, [30,34]
|
2
|
GFAP
|
NM_002055
|
glial fibrillary acidic protein
|
literature, [29]
|
3
|
CP
|
NM_000096
|
ceruloplasmin
|
literature, [53]
|
4
|
DYRK1A
|
NM_001396
|
dual-specificity tyrosine-(Y) phosphorylationregulated kinase 1A
|
literature, [74]
|
5
|
FKBP1A
|
NM_000801
|
FK506 binding protein 1A
|
literature, [57]
|
6
|
FTL
|
BC058820
|
ferritin, light polypeptide
|
literature [3,34,52]
|
7
|
M6PR
|
NM_002355
|
mannose-6-phosphate receptor
|
literature, [75]
|
8
|
MAP2
|
NM_031846
|
microtubule-associated protein 2
|
literature, [3]
|
9
|
MBP
|
BC008749
|
myelin basic protein
|
literature, [49]
|
10
|
MT1F
|
NM_005949
|
metallothionein 1F
|
literature, [31]
|
11
|
RPL23
|
BC010114
|
ribosomal protein L23
|
literature, [3]
|
12
|
RPS27
|
NM_001030
|
ribosomal protein S27
|
literature, [76]
|
13
|
VDAC2
|
NM_003375
|
voltage-dependent anion channel 2
|
literature, [77]
|
14
|
YWHAE
|
BC001440
|
tyrosine 3-monooxygenase/tryptophan-5-monooxygenase activation protein, epsilon polypeptide
|
literature, [78]
|
15
|
AGT
|
NM_000029
|
angiotensinogen
|
literature, [34,79]
|
16
|
STXBP1
|
NM_003165
|
syntaxin binding protein 1
|
literature, [3,32], qRT-PCR did not show significant change
|
17
|
KNS2
|
BC008881
|
kinesin 2 60/70kDa
|
inferred, up regulated in injured optic nerve, [33], qRT-PCR did not show significant change
|
18
|
C21orf33
|
NM_004649
|
chromosome 21 open reading frame 33
|
inferred, elevated in fetal Down syndrome brain, [80]
|
19
|
FKBP2
|
NM_057092
|
FK506 binding protein 2
|
inferred, [57]
|
20
|
FREQ
|
NM_014286
|
frequenin homolog
|
inferred, up in Schizophrenia, [81]
|
21
|
GRM3
|
NM_000840
|
glutamate receptor, metabotropic 3
|
inferred, GRM2 and 4 increased in ischemic neurodegeneration, [82]
|
22
|
NPTX1
|
NM_002522
|
neuronal pentraxin I
|
inferred, short pentraxins are upregulated in AD, [50]
|
23
|
PDE8A
|
NM_002605
|
phosphodiesterase 8A
|
inferred, family member of PDE8B, is upregulated in AD, [83]
|
24
|
AHCTF1
|
AB059277
|
AT hook containing transcription factor 1
|
qRT-PCR
|
25
|
APRIN
|
NM_015032
|
androgen-induced proliferation inhibitor
|
qRT-PCR
|
26
|
CENTG2
|
NM_014914
|
centaurin, gamma 2
|
qRT-PCR
|
27
|
LMNA
|
NM_170708
|
lamin A/C
|
qRT-PCR
|
28
|
PLRG1
|
BC020786
|
pleiotropic regulator 1
|
qRT-PCR
|
29
|
PREPL
|
AB007896
|
prolyl endopeptidase-like
|
qRT-PCR
|
30
|
RPS20
|
NM_001023
|
ribosomal protein S20
|
qRT-PCR
|
31
|
SAFB
|
NM_002967
|
scaffold attachment factor B
|
qRT-PCR
|
32
|
SPTBN2
|
NM_006946
|
spectrin, beta, non-erythrocytic 2
|
qRT-PCR
|
33
|
SRGAP2
|
XM_059095
|
SLIT-ROBO Rho GTPase activating protein 2
|
qRT-PCR
|
34
|
USP10
|
NM_005153
|
ubiquitin specific protease 10
|
qRT-PCR
|
35
|
ARHGAP1
|
NM_004308
|
Rho GTPase activating protein 1 (CDC42GAP)
|
qRT-PCR, inferred, CDC42 is upregulated in AD, [60]
|
36
|
DRD1IP
|
NM_015722
|
dopamine receptor D1 interacting protein
|
qRT-PCR, inferred, up regulated in schizophrenia, [84]
|
37
|
MARK2
|
BC008771
|
MAP/microtubule affinity-regulating kinase 2
|
qRT-PCR, inferred, [85]
|
38
|
SCARB2
|
NM_005506
|
scavenger receptor class B, member 2, CD36 antigen
|
qRT-PCR, Inferred, inflammation increases CD36 mRNA, thus induceCD36 antigen, [51]
|
39
|
SEPT6
|
NM_015129
|
septin 6
|
qRT-PCR, inferred, increased in motor deficient mice,[86]
|
40
|
SKP1A
|
NM_170679
|
S-phase kinase-associated protein 1A
|
qRT-PCR, inferred, overexpression of SKP1A together with APP increase the production of Aβ, [87]
|